ŌURA (see Pulse 2.0 profile here), the company behind the popular ŌURA Ring wearable device, has confidentially filed for an initial public offering in the United States, positioning itself to become one of the most closely watched consumer health technology IPOs in recent years
The confidential filing allows ŌURA to begin the IPO process privately with the U.S. Securities and Exchange Commission before publicly disclosing its financial details and offering terms. While the company has not yet revealed how many shares it plans to sell or the expected valuation range for the offering, the move signals that ŌURA believes market conditions are favorable for a public debut.
Founded in Finland in 2013, ŌURA initially gained attention for its sleek smart ring that focused heavily on sleep tracking and recovery analytics. Over the past several years, the company has evolved into a broader health monitoring platform, offering users insights into sleep quality, readiness, stress, heart rate variability, activity, recovery, and overall wellness
The ŌURA Ring became especially popular among athletes, executives, celebrities, and health-conscious consumers seeking an alternative to traditional smartwatches. Its minimalist design and emphasis on passive health monitoring helped differentiate the company in the growing wearable technology market
ŌURA’s expansion into deeper health analytics has accelerated significantly over the last two years. The company has introduced new features focused on cardiovascular health, stress detection, women’s health tracking, illness detection, meal analysis, and AI-powered wellness guidance. Oura has also invested heavily in artificial intelligence capabilities designed to provide more personalized health recommendations to users.
The company’s growth has attracted substantial investor interest. ŌURA was reportedly valued at approximately $11 billion following a large funding round completed in late 2025. That financing included participation from major investment firms and further cemented ŌURA’s status as one of the leading companies in the wearable health technology sector
ŌURA has also continued expanding its subscription business model, which has become an increasingly important revenue driver. Users pay monthly subscription fees to access advanced analytics, personalized insights, and premium health features through the company’s platform. The recurring revenue structure has helped strengthen ŌURA’s financial profile ahead of its anticipated public market debut.
According to recent reports, ŌURA is on track to surpass 5 million paid members this quarter. The company has also reportedly been approaching annualized revenue figures exceeding $1 billion, highlighting the scale of its business growth as consumer interest in preventive health technologies continues rising
Partnerships have also played an important role in ŌURA’s expansion strategy. The company previously announced collaborations involving metabolic health and glucose monitoring technologies, helping position ŌURA as a broader health ecosystem platform rather than simply a hardware manufacturer
The confidential IPO filing comes during a period of renewed momentum in the public markets for technology and AI-related companies. Investors have shown increasing interest in businesses tied to digital health, wellness, artificial intelligence, and connected consumer devices
At the same time, competition in the smart ring market is intensifying. Large technology companies and consumer electronics manufacturers have increasingly focused on wearable health devices as a major growth category. Samsung has already entered the smart ring market, while reports have suggested Apple has explored similar wearable concepts
Despite the growing competition, ŌURA has maintained a strong position in the premium smart ring segment due to its brand recognition, subscription ecosystem, and early leadership in health-focused wearable analytics
If the IPO moves forward successfully, ŌURA could become one of the largest and most prominent wearable technology companies to enter the public markets in recent years. The offering may also serve as an important indicator of investor appetite for consumer health-tech companies and subscription-based wearable platforms
